We are advocates for kids.

We are advocates for kids. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

We are advocates for kids. Abstract Text:

Stanford Shulman,Stanford Shulman,

We are advocates for kids. Publishing Authors By Initials

S Shulman,S Shulman,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

We are advocates for kids. Journal Published:

PUBLICATION TYPE: Editorial

Journal: Pediatric annals

VOLUME: 36

Page Numbers: 622-3

Journal Abbreviation:

ISSN: 0090-4481

DAY: 30

MONTH: Oct

YEAR: 2007

We are advocates for kids. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 356657

We are advocates for kids. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: We are advocates for kids. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for We are advocates for kids.

AFFILIATION:

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Pediatr Ann

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

We are advocates for kids Related Publications

• Acute ethanol toxicity from ingesting mouthwash in children younger than age 6, 1989-2003.
• Advanced environmental surveillance and molecular analyses indicate separate importations rather than endemic circulation of wild type 1 poliovirus in Gaza district in 2002.
• Androgens and menopause: more fuel for the fire.
• Be a sport (doc).
• Brachial neuralgia.
• Combination of flocculation tests in the differential diagnosis of jaundice.
• Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity.
• Dicumarol poisoning; report of a case.
• Impressions of physical medicine in the United States of America.
• Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.
• Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease.
• Isolation and properties of thyroglobulin-related 4S protein in the soluble fraction of thyroid tissue.
• Keeping the record straight.
• Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis.
• Medication reconciliation in ambulatory oncology.
• Microscopical observations on the effects of phenanthroline chelates on Landschütz ascites tumour cells.
• Mitochondrial GTP regulates glucose-stimulated insulin secretion.
• Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance.
• Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.
• New insights into the pathogenesis of insulin resistance in humans using magnetic resonance spectroscopy.
• Phenergan (R. P. 3277) preliminary report of clinical effectiveness.
• Psychopharmacology.
• Recurrent abdominal pain and irritable bowel syndrome in children.
• Rheumatic heart disease in developing countries.
• Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance.
• Texas dentists' attitudes toward the Dental Medicaid program.
• The blocking of antibodies in vivo; preliminary investigation.
• The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome.
• We are advocates for kids.
• n-3 Fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator-activated receptor-alpha-dependent manner.